Year: 2012

CCSN Director Elaine Dean was interviewed by CTV News about the results of the ATLAS (Adjuvant Tamoxifen — Longer Against Shorter) study announced at the San Antonio Breast Cancer Symposium. This study found that ten years of adjuvant treatment with tamoxifen provided women with estrogen receptor-positive breast cancer greater protection against late recurrence and death from breast cancer compared with the current standard of five years of tamoxifen. The interview

Tiffany Glover, CCSN Policy & Public Affairs Manager, attended the Ontario Health Coalition (OHC) Assembly and Conference in Toronto on November 17-18, 2012. The discussion topic for the first day of the conference was protecting health care in the face of austerity, and included briefings on charting the electoral landscape, key issues and strategies of the political parties, opportunities and challenges under a minority government,

Canadians underestimate difficulty of coping with prostate cancer’s impact on sex life TORONTO Nov 29, 2012: Two recent Leger Marketing surveys probing Canadians’ perceptions of the most difficult things to deal with if faced with a diagnosis of prostate cancer illustrate a significant gap in appreciating quality of life issues associated with the disease. For instance, according to the surveys, while Canadians in general (32%) and men

November 12, 2012 – The Canadian Cancer Survivor Network is deeply concerned that men, in British Columbia, with advanced prostate cancer that has spread to their bones are not receiving the same evidence-based care as patients in other provinces. Patients in British Columbia are being denied access to bone targeted treatment at the appropriate time in therapy. Men whose cancer has spread, or metastasised, to their

Jackie Manthorne, Canadian Cancer Survivor Network President & CEO made a presentation entitled Involvement of patients and survivors in advocacy and public policy development at the Canadian Cancer Survivor Network as part of the session Cancer care, survivorship, pain control and palliative care at the 22nd World Cancer Congress held in Montreal in late August, 2012. Manthorne’s presentation is now published in PDF format on the Union